Scarica l'app Stockscreener
0.8674
4.12%
0.0343
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Biocardia Inc Borsa (BCDA) Ultime notizie
BioCardia Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BioCardia (NASDAQ: BCDA) raises $4.9M and updates Nasdaq listing compliance - Stock Titan
BioCardia shares rally after FDA supports regulatory path for heart failure therapy (BCDA) - MSN
BCDA Reiterated by HC Wainwright & Co. -- Price Target Maintained at $25 - GuruFocus
BioCardia CEO Peter Altman buys $4,250 in company stock - Investing.com
BioCardia (BCDA) CEO Peter Altman adds 5,000 shares in open-market buy - Stock Titan
Why did BCDA stock surge more than 50% today? - MSN
BioCardia's $4.4M Lifeline: Fuel for Japan, But For How Long? - BriefGlance
Biocardia raises $4.5 million through share sale By Investing.com - Investing.com Nigeria
BioCardia Announces $4.4 Million Financing to Extend Cash Runway Into 2027 and Support Japan PMA Submission 9 - Minichart
Biocardia raises $4.5 million through share sale - Investing.com
BioCardia, Inc. Raises $4.48 Million to Extend Cash Runway into 2027 Ahead of PMDA Submission - Quiver Quantitative
BioCardia Announces $4.4 Million Financing - The Manila Times
BioCardia sells 3.51M shares for $4.49M to extend cash runway into early 2027 - TradingView
BioCardia (NASDAQ: BCDA) extends cash runway with $4.4M equity raise - Stock Titan
BCDA Stock Surges As FDA Softens Trial Requirements For CardiAMP - timothysykes.com
BioCardia Company Profile & Introduction - Moomoo
BCDA Surges As BioCardia Wins Key FDA Trial Backing - StocksToTrade
Why Is BioCardia Stock Gaining Friday? - Sahm
BCDA Surges As BioCardia Wins FDA PMA Pathway Nod - timothysykes.com
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$BioCardia (BCDA.US)$ all in all..got a good trade..big profits..but thats all for now..gl all - Moomoo
BioCardia (BCDA) Advances CardiAMP Cell Therapy Approval Process - GuruFocus
BioCardia Jumps After FDA Feedback Seen Positive for CardiAMP Approval - TechStock²
BioCardia jumps after FDA minutes clarify PMA path for CardiAMP HF II trial - Quiver Quantitative
$BioCardia (BCDA.US)$ 🚀🚀🚀 - Moomoo
BioCardia Shares Rally After FDA Supports Regulatory Path for Heart Failure Therapy (BCDA) - Yahoo Finance
BioCardia’s CardiAMP HF II Clinical Trial May Support FDA Premarket Approval for Cell Therapy in Heart Failure - Minichart
BCDA Stock Jumps As FDA Clears Path For Helix Catheter - StocksToTrade
$BioCardia (BCDA.US)$ - Moomoo
BCDA Stock Holds Key Support As FDA Clears Paths For Helix - timothysykes.com
BioCardia stock surges on FDA trial pathway confirmation By Investing.com - Investing.com India
BioCardia stock surges on FDA trial pathway confirmation - Investing.com
BioCardia receives FDA feedback on heart failure trial pathway By Investing.com - Investing.com India
BioCardia receives FDA feedback on heart failure trial pathway - Investing.com
BioCardia® Receives FDA Minutes Confirming Eligibility for Premarket Approval of CardiAMP Cell Therapy for Ischemic Heart Failure - Quiver Quantitative
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF - The Manila Times
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
FDA minutes support BioCardia (NASDAQ: BCDA) CardiAMP HF II PMA pathway - Stock Titan
FDA flags heart failure cell therapy trial that may aid 1M patients - Stock Titan
BioCardia outlines Japan Shonin filing in ~7 months and targets ~19-month path to approval for CardiAMP - MSN
BCDA Stock Price, Quote & Chart | BIOCARDIA INC (NASDAQ:BCDA) - ChartMill
BioCardia receives regulatory guidance from Japan’s PMDA - Investing.com UK
BioCardia receives regulatory guidance from Japan’s PMDA By Investing.com - Investing.com South Africa
BioCardia, Inc. (BCDA) Files 8-K with SEC: Company Details, Stock Info, and Contact Information (May 28, 2026) - Minichart
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):